Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy

BACKGROUND: To evaluate the organ-specific therapeutic effect of pembrolizumab after the failure of platinum-based chemotherapy for advanced urothelial carcinoma (UC). MATERIALS AND METHODS: Patients with advanced UC who received pembrolizumab after the failure of platinum-based chemotherapy and who...

Descripción completa

Detalles Bibliográficos
Autores principales: Furubayashi, Nobuki, Negishi, Takahito, Sakamoto, Naotaka, Shimokawa, Hozumi, Morokuma, Futoshi, Song, Yoohyun, Hori, Yoshifumi, Tomoda, Toshihisa, Tokuda, Noriaki, Seki, Narihito, Kuroiwa, Kentaro, Nakamura, Motonobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987306/
https://www.ncbi.nlm.nih.gov/pubmed/33776447
http://dx.doi.org/10.2147/OTT.S299724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987306/
https://www.ncbi.nlm.nih.gov/pubmed/33776447
http://dx.doi.org/10.2147/OTT.S299724

Ejemplares similares